Table of Contents
- 1 Dose comes to add to the strategy
- 2 They are provided in Primary Care centres
- 3 What role do community outreach and education play in mitigating vaccine hesitancy related to the Bexsero booster dose, and how are healthcare providers being equipped to communicate effectively with parents about its importance?
From November 1, 2024, a booster dose of the Bexsero vaccine al national vaccination scheme, including the Ñuble Division.
The dose is one meningococcal vaccine what prevent meningitis B This vaccine can be given for children and babies from two months of age. In this case, the reinforcement is aimed at boys and girls of 18 months who received the first doses before at 2 and 4 months old.
Read also: Products with listeria found in Cecinas Belén de San Carlos and its activity suspended
The vaccination is free and is fully available primary health centers of the country. The measure aims to increase protection against meningococcal meningitisa bacterial infection that can enter the memran which protects the brain and spinal cord.
In severe cases, this disease can cause septicemiawidespread disease in the blood a affecting vital organs. According to the Ministry of Healthin 2024 an increase in infections was recordedwhich prompted the need to introduce this reinforcement.
Dose comes to add to the strategy
The Ñuble Health SeremiMichelle de Arcas explained that this vaccine complements vaccination strategies to prevent serious complications.
“Including this vaccine It is a huge step forward to protect our babies against serious diseases such as meningococcal meningitis,” he said.
The authority said that the vaccination is safe and it has very few side effectsurging families to vaccinate their children in the health centers.
Booster doses are available as part of the National Immunization Program (PNI)which includes vaccines for 23 vaccine-preventable diseases.
They are provided in Primary Care centres
For his part, the director of the Ñuble Health ServiceElizabeth Abarca, that this step will reduce serious cases and hospitals in youth.
“Vaccination not only protects children, but also contributes to reduce community spread of this bacteria”, he noted. he is Vaccination plan has achieved coverage 98% in the two initial doses of Bexsero, included in the scheme from July 2023.
The authorities confirmed that a network of primary care willing to provide this vaccine throughout the country. CESFAMs, CECOFs and Ñuble offices They are part of the institutions that provide the dose.
Keep reading: 44 thousand people in Ñuble suffer from diabetes type 2: the number increased by 7% this year
2024-11-20 11:32:00
#Ñuble #health #centers #provide #booster #vaccination #meningitis #FONTANA
1. Can you elaborate on the significance of implementing a booster dose of the Bexsero vaccine in national vaccination schemes, particularly in Ñuble Division? How does this initiative help protect against meningitis B?
2. What are the expected outcomes for the healthcare system and the community as a whole with this reinforcement to the National Immunization Program (PNI)? Do you anticipate a reduction in the incidence of meningococcal meningitis or septicemia cases?
3. Can you provide insights into how this vaccination plan aligns with broader strategies to prevent and control infectious diseases in Chile? Are there any challenges or limitations that need to be addressed?
4. What impact does the introduction of a new vaccine have on the existing immunization infrastructure, such as primary health centers and primary care providers? Are there enough resources and trained professionals to ensure successful implementation of the program?
5. What measures are being taken to raise awareness about the importance of the booster dose and address any potential vaccine hesitancy among parents or caregivers? How can we ensure that families take their children to receive the vaccination at the recommended age?
6. Could you discuss the logistics of the vaccination process, including where parents and caregivers can go to receive the booster dose and any potential side effects they should be aware of?
7. how will the success of this initiative be evaluated, and what steps are being taken to maintain the high vaccination coverage rates achieved thus far?
